Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kangai Jingfang is a traditional Chinese medicine formula, also referred to as Anticancer Essence Formula, that is being investigated for its therapeutic potential in treating advanced colorectal cancer. It is specifically studied for stage III - IV colorectal cancer characterized by spleen deficiency and essence deficiency types. The drug is administered orally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kangai Jingfang.